Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
about
Structural and functional diversity of the microbial kinomeProtein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligaseNEMO/NLK phosphorylates PERIOD to initiate a time-delay phosphorylation circuit that sets circadian clock speedGapped alignment of protein sequence motifs through Monte Carlo optimization of a hidden Markov modelAutomatic discovery of cross-family sequence features associated with protein function.JNK Signaling: Regulation and Functions Based on Complex Protein-Protein PartnershipsRedox regulation of FoxO transcription factorsDesign principles underpinning the regulatory diversity of protein kinasesThe Cryptosporidium parvum KinomeThe structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteineDusty protein kinases: primary structure, gene evolution, tissue specific expression and unique features of the catalytic domainSUMOylation of the Forkhead transcription factor FOXL2 promotes its stabilization/activation through transient recruitment to PML bodiesMolecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug designCo-conserved MAPK features couple D-domain docking groove to distal allosteric sites via the C-terminal flanking tailA chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibitionNMR Characterization of Information Flow and Allosteric Communities in the MAP Kinase p38γSubstrate and docking interactions in serine/threonine protein kinasesCo-conserved features associated with cis regulation of ErbB tyrosine kinases.Phosphorylation of the transcription activator CLOCK regulates progression through a ∼ 24-h feedback loop to influence the circadian period in Drosophila.Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa.The p38β mitogen-activated protein kinase possesses an intrinsic autophosphorylation activity, generated by a short region composed of the α-G helix and MAPK insert.A hierarchical phosphorylation cascade that regulates the timing of PERIOD nuclear entry reveals novel roles for proline-directed kinases and GSK-3beta/SGG in circadian clocks.Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability.Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.Structural and evolutionary adaptation of rhoptry kinases and pseudokinases, a family of coccidian virulence factorsDYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discoveryInference of Functionally-Relevant N-acetyltransferase Residues Based on Statistical Correlations.Functional flexibility of human cyclin-dependent kinase-2 and its evolutionary conservation.Analogous regulatory sites within the alphaC-beta4 loop regions of ZAP-70 tyrosine kinase and AGC kinases.The phospho-occupancy of an atypical SLIMB-binding site on PERIOD that is phosphorylated by DOUBLETIME controls the pace of the clock.The annotation of both human and mouse kinomes in UniProtKB/Swiss-Prot: one small step in manual annotation, one giant leap for full comprehension of genomes.Identification, nomenclature, and evolutionary relationships of mitogen-activated protein kinase (MAPK) genes in soybean.TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.Activation, regulation, and inhibition of DYRK1A.Regulation of splicing by SR proteins and SR protein-specific kinases.GSK-3β, a pivotal kinase in Alzheimer disease.KinView: a visual comparative sequence analysis tool for integrated kinome research.The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters Through a Rho-Dependent Mechanism.Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors.
P2860
Q21563604-4CC29476-CDA9-4177-BC04-603D65E83A0FQ24321736-2DBD857F-F2E3-4FAF-BF4D-59495EE8F5E5Q24594785-687A7B49-BD26-4D97-A3ED-2CD902F76918Q24808652-658652E1-3216-4C0E-B13E-8E575FC57107Q25255690-342ADC9C-DA25-4A23-A870-387560027A5DQ26741279-40BE4D9B-698A-40FD-B03E-1EFA60E3FBD7Q26799843-C68AC170-8E5B-40E5-8CDA-C14AB8A7C939Q27027644-44664C90-8EC5-456F-B9F0-6070A63A8C3DQ27674622-8018B866-F5B0-40E2-8B15-8921EA597761Q27700733-C59BC825-A687-4577-9D0F-086EA4A84D92Q28275380-78F3048B-84E4-44F6-B985-44738AF9A399Q28477459-2186631C-5A08-41EE-89D3-0FF9BF9AA287Q28533443-7145C895-87A3-4BE1-9BA2-C94E1289B675Q28544906-FD4179A3-5931-4E96-B895-0E4AF1107038Q28828212-5D85059B-8B66-48C6-BE36-FE98B240DBBAQ28828493-3C14F2DD-86AB-48F1-B39C-75B80FDF501BQ33576177-D4CA2A08-280A-4DC4-BD2F-C202DC0B3772Q33778237-33612CF7-77A3-4FBC-A35A-3D45CCB6F316Q33888611-0E7E801A-BFC1-446C-91ED-5B99081015AFQ34065070-3F096355-D550-469F-9045-99F467004E9CQ34140902-DE406CF9-879E-41C6-BAC0-CAA57A80C327Q34213033-6CF4314D-33D5-4C88-8038-8A2BAF6732DDQ34215427-8BC91EE0-3827-4797-BB3D-0F2B249750AFQ34546438-7662A4B3-2398-47C5-B387-39B70DE04D2AQ34761765-8348DD40-32BC-4739-AF37-8C116E70C050Q34807677-E540F1B6-F8E2-4864-946D-BDA6CEB43D0DQ35136572-24FC1079-56E4-46BA-8A45-4EF2764F61A4Q36230487-696A7B26-68C8-4999-810D-E63EE2B19AAFQ36281964-E56968E2-D48C-4827-818C-CC721565AAC8Q36484882-E5EEB599-6AD6-4A85-8318-A04C9D8BE039Q36802821-BD115331-528F-43E4-B78B-86CFFACA1477Q36818142-CADE1248-5DEC-43F2-A76E-148F879A1F0BQ37203059-50FE6BD6-4692-4AF7-8540-B6A563DA7C10Q37219806-F068FA0B-4A0D-4D41-B152-70780B29AA2BQ37815234-DE880542-FD04-47EB-AF6D-8D98FB7F34D0Q38092678-86B87A0C-9550-4D51-8FC9-88DFEA8DD675Q38218085-14985F4E-CB8F-4F3C-B05B-4D45EE8CB411Q38407314-66137E83-56EF-4F1C-8674-A54226BD1DE6Q38429066-3B735DAC-DEDE-423D-B2B3-0C7735AF626EQ39008696-70A11F6A-6B26-468A-BBF2-5A48E060AA5D
P2860
Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@ast
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@en
type
label
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@ast
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@en
prefLabel
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@ast
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@en
P2860
P356
P1433
P1476
Evolutionary constraints assoc ...... GSK, SRPK, DYRK, and CK2alpha.
@en
P2093
Andrew F Neuwald
Natarajan Kannan
P2860
P304
P356
10.1110/PS.04637904
P577
2004-08-01T00:00:00Z